Nia Therapeutics Raises $8.5 Million
Penn spinout Nia Therapeutics recently raised $8.5 million in an equity financing round.
Capstan raises $175M Series B
Proceeds from the financing will be used to advance Capstan's lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, CPTX2309, to early clinical proof-of-concept in autoimmune disorders.
iEcure Gains FDA approval to Conduct FirstGene Therapy Treatment
Utilizing ARCUS, a gene editing tool developed by Precision BioSciences, the therapy aims to provide a lifelong fix for this disease, potentially benefiting thousands of individuals in the US alone.
Penn Startup Profile: Baleena’s Continued Emergence and Growth
Baleena is focused on developing a consumer product that attaches to the inside of a washing machine drum to filter out microfibers.
Three Penn Startups Recognized on Technical.ly Philadelphia’s 2024 RealLIST Startups list
This year, Penn spinouts BlueWhale Bio and Baleena, ranked number one and two on the RealLIST respectively.
Scout Bio Acquired by Leading Animal Health Company
French company Ceva Santé Animale announced that it is acquiring Scout Bio.
Y-Prize Goes to LilyLoop, a feminine product that captures menstrual flow data for improved diagnostics
LilyLoop, which proposed a commercial application for Penn’s biodegradeable moisture sensors, is the winner of the Mack Institute for Innovation Management’s 2024 Y-Prize Competition.
PCIV Company OmnicPath AI Published in Nature BioTechnology
OmnicPath AI specializes in developing an end-to-end workflow that integrates Spatial Transcriptomics (ST) data and high-resolution histology images to predict spatial gene expression.
Robotics Growth in Philadelphia Highlighted
The Philadelphia Business Journal recently released an article about robotics growth in Philadelphia.
Penn Spinout EpiVario Announces Acquisition of Acetyl CoA Synthetase 2 (ACSS2) Inhibitor Portfolio from Metabomed LTD
Penn spinout EpiVario, a biotech company focusing on neuroepigenetics for addiction disorders, has acquired small molecule acetyl co-A synthetase-2 inhibitor (ACSS2i) portfolio.